[1]李沛隆,连 杰,林 娜,等.白细胞介素-33与儿童支气管哮喘的相关性研究进展[J].新乡医学院学报,2021,38(4):374-377.[doi:10.7683/xxyxyxb.2021.04.017]
点击复制

白细胞介素-33与儿童支气管哮喘的相关性研究进展
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
38
期数:
2021年4
页码:
374-377
栏目:
综述
出版日期:
2021-04-05

文章信息/Info

作者:
李沛隆12连 杰12林 娜1刘运广1
(1.右江民族医学院附属医院儿科,广西 百色 533000;2.右江民族医学院研究生学院,广西 百色 533000)
关键词:
儿童哮喘白细胞介素-33膜结合受体ST2
分类号:
R562.2
DOI:
10.7683/xxyxyxb.2021.04.017
文献标志码:
A
摘要:
白细胞介素(IL)-33是一种来自IL-1家族的报警因子,通过与其受体结合的形式发挥作用,其受体主要附着于免疫细胞。近年来,因IL-33在炎症性疾病中的作用而成为众多研究的焦点。在儿童支气管哮喘中,IL-33已被证实是诱导哮喘发生和发展的重要因子。为进一步了解IL-33 在支气管哮喘中的作用,本文对国内外学者的最新研究成果进行综述。

参考文献/References:

[1] BARNIG C,FROSSARD N,LEVY B D.Towards targeting resolution pathways of airway inflammation in asthma[J].Pharmacol Ther,2018,186:98-113.
[2] 张鑫,王炜,孙英.上皮源性细胞因子IL-33、IL-25和TSLP在哮喘发病机制中的作用[J].微生物学免疫学进展,2017,45(5):53-58.
[3] 周炜,朱明哲.小儿哮喘非急性发作期IgE、EOS、LTE-4检测及其临床意义[J].现代养生,2018(2):130-131.
[4] GUO Z,WU J,ZHAO J,et al.IL-33 promotes airway remodeling and is a marker of asthma disease severity[J].Asthma,2014,51(8):863-869.
[5] MARTIN N T,MARTIN M U.Interleukin 33 is a guardian of barriers and a local alarmin[J].Nat Immunol,2016,17(2):122-131.
[6] GROTENBOER N S,KETELAAR M E,KOPPELMAN G H,et al.Decoding asthma:translating genetic variation in IL33 and IL1RL1 into disease pathophysiology[J].Allergy Clin Immunol,2013,131(3):856-865.
[7] PICHERY M,MIREY E,MERCIER P,et al.Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues,lymphoid organs,brain,embryos,and inflamed tissues:in situ analysis using a novel IL-33-LacZ gene trap reporter strain[J].J Immunol,2012,188(7):3488-3495.
[8] GUPTA R K,GUPTA K,DWIVEDI P D.Pathophysiology of IL-33 and IL-17 in allergic disorders[J].Cytokine Growth Factor Rev,2017,38:22-36.
[9] TOMINAGA S.A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor[J].FEBS Lett,1989,258(2):301-304.
[10] LIM E J,TORRESI J.Prevention of hepatitis C virus infection and liver cancer[J].Recent Results Cancer Res,2014,193:113-133.
[11] BOUFFI C,ROCHMAN M,ZUST C B,et al.IL-33 markedly activates murine eosinophils by an NF-κB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loop[J].J Immunol,2013,191(8):4317-4325.
[12] 李鑫,刘圆圆,张才擎.白介素-33在支气管哮喘发病机制中的作用[J].中华临床医师杂志:电子版,2019,13(5):389-392.DOI:10.3877/cma.j.issn.1674-0785.2019.05.014.
[13] ENDO Y,HIRAHARA K,LINUMA T,et al.The interleukin-33-p38 kinase axis confers memory T helper 2 cell pathogenicity in the airway[J].Immunity,2015,42(2):294-308.
[14] CANBAZ D,UTSCH L,LOGIANTARA A,et al.IL-33 promotes the induction of immunoglobulin production after inhalation of house dust mite extract in mice[J].Allergy,2015,70(5):522-532.
[15] SUN B,ZHU L,TAO Y,et al.Characterization and allergic role of IL-33-induced neutrophil polarization[J].Cell Mol Immunol,2018,15(8):782-793.
[16] BHOWMIK M,MAJUMDAR S,DASGUPTA A,et al.Pilot-scale study of human plasma proteomics identifies apoE and IL33 as markers in atopic asthma[J].Allergy Clin Immunol,2019,12:273-283
[17] SAVENIJE O E,MAHACHIE J M,GRANELL R,et al.Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood[J].Allergy Clin Immunol,2014,134(1):170-177.
[18] SCHRODER P C,CASACA V I,ILLI S,et al.IL-33 polymorphisms are associated with increased risk of hay fever and reduced regulatory T cells in a birth cohort[J].Pediatr Allergy Immunol,2016,27(7):687-695.
[19] KIM H Y,CHANG Y J,SUBRAMANIAN S,et al.Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity indepen-dently of adaptive immunity[J].Allergy Clin Immunol,2012,129(1):216-227.
[20] SAGLANI S,LUI S,ULLMANN N,et al.IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma[J].Allergy Clin Immunol,2013,132(3):676-685.
[21] SHAN S,LI Y,WANG J,et al.Nasal administration of interleukin-33 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma surrogate[J].Immunology,2016,148(1):83-91.
[22] KAUR D,GOMEZ E,DOE C,et al.IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell:airway smooth muscle crosstalk[J].Allergy,2015,70(5):556-567.
[23] BESNARD A G,TOGBE D,GUILLOU N,et al.IL-33-activated dendritic cells are critical for allergic airway inflammation[J].Eur J Immunol,2011,41(6):1675-1686.
[24] CHRISTIANSON C A,GOPLEN N P,ZAFAR I,et al.Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33[J].Allergy Clin Immunol,2015,136(1):59-68.
[25] SJOBERG L C,GREGORY J A,DAHLEN S E,et al.Interleukin-33 exacerbates allergic bronchoconstriction in the mice via activation of mast cells[J].Allergy,2015,70(5):514-521
[26] ZOLTOWSKA A M,LEI Y,ADNER M,et al.Mast cell-dependent IL-33/ST2 signaling is protective against the development of airway hyperresponsiveness in a house dust mite mouse model of asthma[J].Am J Physiol Lung Cell Mol Physiol,2018,314(3):484-492.
[27] CHEN C C,KOBAYASHI T,LIJIMA K,et al.IL-33 dysregulates regulatory T cells and impairs established immunological tolerance in the lungs[J].Allergy Clin Immunol,2017,140(5):1351-1363.
[28] MORITA H,ARAE K,UNNO H,et al.An interleukin-33-mast cell-interleukin-2 axis suppresses papain-induced allergic inflammation by promoting regulatory T cell numbers[J].Immunity,2015,43(1):175-186.
[29] JACKSON D J,MAKRINIOTI H,RANA B M,et al.IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo[J].Am J Physiol Lung Cell Mol Physiol,2014,190(12):1373-1382.
[30] LYNCH J P,WERDER R B,SIMPSON J,et al.Aeroallergen-induced IL-33 predisposes to respiratory virus-induced asthma by dampening antiviral immunity[J].Allergy Clin Immunol,2016,138(5),1326-1337.
[31] CASTANHINHA S,SHERBURN R,WALKERR S,et al.Pedia-tric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33[J].Allergy Clin Immunol,2015,136(2):312-322.
[32] ALLINNE J,SCOTT G,LIM W K,et al.IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation[J].Allergy Clin Immunol,2019,144(4):1624-1637.
[33] HANANIA N A,MOONAN M,CORREN J,et al.Lebrikizumab in moderateto-severe asthma:pooled data from two randomized placebocontrolled studies[J].Thorax,2015,70(8):748-756.
[34] QIU C,LI Y,LI M,et al.Anti-interleukin-33 inhibits cigarette smoke-induced lung inflammation in mice[J].Immunology,2013,138(1):76-82.
[35] LEE H Y,RHEE C K,KANG J Y,et al.Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma[J].Exp Lung Res,2014,40(2):66-76.

相似文献/References:

[1]元帅,史世峰,孙丽君,等.儿童行为问题研究现状[J].新乡医学院学报,,():000.
[2]于贵珍,郑素华,张文林,等.1120例儿童及青少年行为问题的调查研究[J].新乡医学院学报,1990,7(03):201.
[3]田明德.儿童转换型癔症25例报告[J].新乡医学院学报,1990,7(03):221.
[4]张华荣,卢振民,冯连铭,等.儿童急性中耳炎鼓膜穿孔的探讨[J].新乡医学院学报,1993,10(01):033.
[5]石太新,赵卫星,王礼周,等.小儿再生障碍性贫血骨髓细胞核仁形成区蛋白定量研究[J].新乡医学院学报,1995,12(02):147.
[6]席鸿钧,陈莹,李汉臣,等.经胃壁潜道食管胃粘膜腔内吻合治疗小儿食管狭窄[J].新乡医学院学报,1995,12(03):230.
[7]薛克修,陈金兰,支凌翔,等.儿童前臂缺血性挛缩的治疗[J].新乡医学院学报,1996,13(04):384.
[8]殷琪.儿童特发性高钙尿症12例[J].新乡医学院学报,1996,13(01):091.
[9]郑素华,付桂玲,张文林,等.行为异常儿童社交能力分析[J].新乡医学院学报,1997,14(04):363.
[10]贾东萱,石太新,贾汝贤,等.小儿恶性肿瘤及白血病226例回顾性分析[J].新乡医学院学报,1997,14(04):405.

更新日期/Last Update: 2021-04-05